ERBB2 and breast carcinoma: Furthermore, we constructed a HER-2-positive breast cancer xenograft tumor model in female mice; consistent with the effects observed in vitro, we found that mice treated with Compound C and aspirin showed tumors with a smaller size and lower expression of SREBP1 and SCD1 compared to those treated with aspirin monotherapy without affecting the overall wellbeing of the mice in all groups.